Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
出版年份 2022 全文链接
标题
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
作者
关键词
-
出版物
BMC CANCER
Volume 22, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-14
DOI
10.1186/s12885-022-09848-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner
- (2022) Shouji Zhang et al. Molecular Therapy-Nucleic Acids
- EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
- (2021) Shunsuke Okamura et al. BMC CANCER
- Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
- (2021) Sushil Kumar et al. Nature Communications
- Overexpression of microRNA‑486 affects the proliferation and chemosensitivity of mesothelioma cell lines by targeting PIM1
- (2021) Silvana Pinelli et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner
- (2021) Peng Wang et al. Frontiers in Cell and Developmental Biology
- He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway
- (2021) Jun Kan et al. PHYTOMEDICINE
- Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3
- (2020) Yujin Li et al. BIOTECHNOLOGY LETTERS
- Propofol Affects Non–Small-Cell Lung Cancer Cell Biology By Regulating the miR-21/PTEN/AKT Pathway In Vitro and In Vivo
- (2020) Xiaoyu Zheng et al. ANESTHESIA AND ANALGESIA
- The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4
- (2020) Zhiwei Xing et al. OncoTargets and Therapy
- Anesthetic propofol epigenetically regulates breast cancer trastuzumab resistance through IL-6/miR-149-5p axis
- (2020) Dan Tian et al. Scientific Reports
- Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
- (2020) Anqi Wang et al. Cancer Medicine
- Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer
- (2020) Wenjing Wang et al. Molecular Cancer
- Monotropein alleviates H2O2‑induced inflammation, oxidative stress and apoptosis via NF‑κB/AP‑1 signaling
- (2020) Feng Jiang et al. Molecular Medicine Reports
- Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1
- (2020) Hongbo Wu et al. Cell Death & Disease
- The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?
- (2020) Chin-King Looi et al. Biomedicines
- miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2
- (2020) Hailian Du et al. Molecular Medicine Reports
- NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity
- (2019) Keywan Mortezaee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
- (2019) Alberto Cruz-Bermúdez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Propofol inhibits pancreatic cancer progress under hypoxia via ADAM 8
- (2019) Yutong Gao et al. Journal of Hepato-Biliary-Pancreatic Sciences
- MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial–mesenchymal transition by targeting twinfilin actin binding protein 1
- (2019) Xiaoyan Jin et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9
- (2019) Chuangzhou Rao et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting NF-κB-Mediated Inflammatory Pathways in Cisplatin-Resistant NSCLC
- (2019) Sarah-Louise Ryan et al. LUNG CANCER
- Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7
- (2019) Xufeng Pan et al. Cell Death & Disease
- MiR-486-5p Serves as a Good Biomarker in Nonsmall Cell Lung Cancer and Suppresses Cell Growth With the Involvement of a Target PIK3R1
- (2019) Fei Tian et al. Frontiers in Genetics
- Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition
- (2019) Shenghu Guo et al. Aging-US
- Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway
- (2019) Mao-mao Zhu et al. BIOMEDICINE & PHARMACOTHERAPY
- Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
- (2019) Dan Wang et al. Journal for ImmunoTherapy of Cancer
- LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis
- (2019) Dong Fu et al. Aging-US
- Pterostilbene Attenuates Astrocytic Inflammation and Neuronal Oxidative Injury After Ischemia-Reperfusion by Inhibiting NF-κB Phosphorylation
- (2019) Haixiao Liu et al. Frontiers in Immunology
- MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A
- (2019) Jinchang Lu et al. EXPERIMENTAL CELL RESEARCH
- Propofol inhibits lung cancer A549 cells growth and epithelial-mesenchymal transition process by up-regulation of microRNA-1284
- (2018) Wei-Zhen Liu et al. ONCOLOGY RESEARCH
- miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer
- (2018) Zhao-jia Gao et al. PATHOLOGY RESEARCH AND PRACTICE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer
- (2017) Nengli Yang et al. ONCOLOGY REPORTS
- Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
- (2017) Lu Xiao et al. Cell Death & Disease
- Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
- (2017) Meng Zhang et al. Cancer Biology & Medicine
- Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
- (2016) Antonio Rossi et al. Expert Review of Anticancer Therapy
- Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer
- (2016) Fei Tian et al. GENE
- PRL-3 activates NF-κB signaling pathway by interacting with RAP1
- (2012) Shenyi Lian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
- (2010) Hsiangling Teo et al. NATURE CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started